Opens in a new tab

Breaking news

This Startup Is Using AI To Revive Failed Drugs: Here’s How It’s Attracting Investors

Ignota Labs, a startup with a unique approach to drug discovery, is using artificial intelligence to breathe new life into drugs that were once abandoned due to safety concerns. The company recently raised $6.9 million in seed funding, a significant sum that highlights the growing investor interest in AI-driven solutions for pharmaceutical innovation.

Led by CEO Sam Windsor, Ignota Labs targets drug candidates that were 80-90% developed but ultimately scrapped due to toxicity issues. Instead of reinventing the wheel, Ignota Labs acquires these “failed” drugs, diagnoses their safety issues using AI, and tweaks the compounds for another shot at clinical trials. Windsor believes this approach could save time and money compared to traditional drug development.

“Traditional drug discovery could cost upwards of $10 million and take seven to eight years just to reach clinical trials,” Windsor explained. “Our approach can achieve the same result in less than two years and for under $1 million.” This pitch resonated with investors, with Montage Ventures and AIX Ventures co-leading the seed round. Other investors, including Modi Ventures, Blue Wire Capital, and Gaingels, also participated.

Ignota Labs stands out in a crowded field of AI drug discovery companies. While many startups focus on creating entirely new drugs, Windsor’s team has chosen to concentrate on refining existing candidates that others have left behind. “In 2021, AI-driven drug discovery was exploding, but most of these companies weren’t addressing the drugs that had already been developed,” Windsor noted. He believes this oversight presents a valuable opportunity, particularly in safety science, which tends to be undervalued by many in the sector.

The company’s AI platform, which analyzes toxicity and suggests chemical modifications, is key to its success. Windsor points out that while safety science may not be the most glamorous part of drug development, it holds immense potential. “Safety is seen as a hurdle to overcome rather than the exciting end goal,” he said. “But this is where we see real opportunity.”

Now, with the fresh capital from the recent funding round, Ignota Labs plans to acquire additional distressed drug assets and advance its first drug—an Alzheimer’s treatment based on a PDE9A inhibitor—into early-stage trials.

Despite the challenging fundraising environment over the past two and a half years, Ignota Labs has found the right backers who believe in its innovative approach to breathing new life into old drug candidates. If successful, Ignota Labs could become a game-changer in the pharmaceutical industry, offering a cost-effective, accelerated path to clinical trials and potentially revolutionizing how the industry views “failed” drugs.

Greek Investment In Cyprus Rises To €9.2 Billion As Both Countries Seek Closer Business Ties

Greek direct investment in Cyprus reached €9.2 billion in June 2026, up nearly two-thirds from €5.6 billion in 2024, as business leaders in both countries seek closer cooperation to expand into international markets.

Invest Cyprus chairman Evgenios Evgeniou announced the figures on Wednesday, adding that Cypriot investment in Greece stood at around €2.7 billion. More than 1,500 businesses with Greek interests operate in Cyprus, while bilateral trade in goods totalled €3.3 billion in 2025. Exports of Cypriot-produced goods to Greece rose by 12%.

Cyprus And Greece Develop Joint Investment Plans

Evgeniou said the countries could combine their business networks to attract international investment. Cyprus has strong links across the Middle East and eastern Mediterranean, while Greece has an established presence in the Balkans and southeastern Europe.

In April, Invest Cyprus and Enterprise Greece renewed their cooperation agreement, paving the way for joint investment initiatives, business delegations and exchanges of expertise. Following a recent meeting with Greece’s deputy foreign minister and Enterprise Greece’s chairman, the parties agreed to develop the memorandum into an action plan with specific initiatives and targets.

The first closed-door meeting with Greek businesses operating in Cyprus is scheduled for early December, with representatives of both governments expected to attend.

Energy And Technology Among Priority Sectors

Energy, defence manufacturing and defence technology are among the sectors identified for closer cooperation. Evgeniou cited the proposed Cyprus-Greece electricity interconnector as an example of the coordination required for major cross-border projects.

Vicky Makrygianni, director of international relations at the Hellenic Federation of Enterprises, said EU trade agreements with Mercosur, India, Canada and Japan could open opportunities that individual companies might struggle to pursue alone. She highlighted potential in energy, agri-food, construction, technology, artificial intelligence and cybersecurity.

Andreas Demetriades, vice-president for the economy at the Cyprus Chamber of Commerce and Industry, said Greece could contribute its industrial base and access to European and Balkan markets, while Cyprus offers financial and professional services, shipping expertise and links to the Middle East and Gulf.

“Together we can create a strong business network that connects three continents,” he said, calling for more joint ventures and closer cooperation between chambers of commerce, including the sharing of investment opportunities.

Makrygianni also noted that Greece could draw on Cyprus’ experience in competitiveness, regulatory simplification and energy security when it assumes the presidency of the Council of the European Union in the second half of 2027.

Nicosia Seeks Tourism And Urban Development Investment

Nicosia mayor Charalambos Prountzos outlined further investment opportunities in the capital. The city aims to increase its share of Cyprus’ tourist arrivals from 5.7% to 10% and raise annual tourism revenue from around €170 million to €400 million by 2029.

Hotel investments exceeding €250 million are expected to double the city’s tourist bed capacity by 2027, with additional projects planned for the historic centre.

Plans also include the redevelopment of 1.4 million square metres in the Sopaz area of eastern Nicosia for businesses, housing and research facilities. Prountzos described the project as “a new city within the city of Nicosia”.

The municipality is working with the government and is open to partnerships with Greek businesses and research organisations, aiming to attract investment while benefiting surrounding neighbourhoods.

Aretilaw firm
The Future Forbes Realty Global Properties
Uol
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter